Sonomind
PrivateLast Round
Series A
May 13, 2026
Total Funding Raised
$27.03M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Sonomind operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in May 2026.
Sonomind is a medical device company that develops non-invasive, personalized neuromodulation technology using low-intensity focused ultrasound to treat depression and other neuropsychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, 3D Printing, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sonomind Comparables
Compare Sonomind with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SPIRE Therapeutics, Inc. | 83% | |
| Neurosona | 81% | |
| Zhongke Green Valley (Shenzhen) Medical Technology Co., Ltd. | 78% |
For institutional investors. Book with your work email.
Sonomind Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 13, 2026 | ||||
| Seed | Sep 24, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sonomind Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Critical Path Ventures | Seed, Series A |
| Bpifrance | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 29, 2026
Grew 31% QoQ, from 13 to 17 employees.
- Jul 17, 2026
Grew 36% QoQ, from 11 to 15 employees.
For institutional investors. Book with your work email.
Sonomind Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sonomind's valuation, stock price, and market status.
Is Sonomind a public or private company?
Sonomind is a private company.
What is the current stock price of Sonomind?
Sonomind is a private company, so its shares have no public market price. Caplight tracks Sonomind's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sonomind worth (valuation)?
Valuation information for Sonomind is not publicly available.
Can I buy Sonomind stock?
Sonomind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sonomind's last funding round?
Sonomind's most recent funding round was Series A on May 13, 2026.
Who are the main investors in Sonomind?
Key investors in Sonomind include Critical Path Ventures, Bpifrance.
Will Sonomind IPO soon?
No public IPO plans have been announced for Sonomind.
How can I track Sonomind secondary market activity?
Caplight tracks bids, offers, and trades in Sonomind's shares on secondary markets.